Phase II study of chemoradiotherapy combined with gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic ductal adenocarcinoma (NUPAT 05 Trial): study protocol for a single arm phase II study

The efficacy of nab-paclitaxel combined with gemcitabine (GnP) and of chemoradiotherapy (CRT) for unresectable locally advanced pancreatic ductal adenocarcinoma (UR-LA PDAC) is still unclear. We previously conducted a phase I study of CRT using GnP and determined the recommended dose and have now de...

Descripción completa

Detalles Bibliográficos
Autores principales: Takano, Nao, Yamada, Suguru, Hirakawa, Akihiro, Yokoyama, Yukihiro, Kawashima, Hiroki, Maeda, Osamu, Okada, Tohru, Ohno, Eizaburo, Yamaguchi, Junpei, Ishikawa, Takuya, Sonohara, Fuminori, Suenaga, Masaya, Takami, Hideki, Hayashi, Masamichi, Niwa, Yukiko, Hirooka, Yoshiki, Ito, Yoshiyuki, Naganawa, Shinji, Ando, Yuichi, Nagino, Masato, Goto, Hidemi, Fujii, Tsutomu, Kodera, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nagoya University 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556455/
https://www.ncbi.nlm.nih.gov/pubmed/31239592
http://dx.doi.org/10.18999/nagjms.81.2.233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556455/
https://www.ncbi.nlm.nih.gov/pubmed/31239592
http://dx.doi.org/10.18999/nagjms.81.2.233

Ejemplares similares